ReviewDrug design, development and therapy2026
Parthenolide and Its Derivatives in the Treatment of Respiratory Tract Diseases: Therapeutic Effects and Molecular Mechanisms.
Yizhu Yao, Yijia Wang, Ping Chen, Dan Yao, Xiaoying Huang, Liangxing Wang
Abstract readReview
In one paragraphReview in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Yizhu Yao *Division of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Yijia Wang *Division of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Ping ChenDivision of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Dan YaoDivision of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Xiaoying HuangDivision of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Liangxing WangDivision of Pulmonary Medicine, Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.ORCID 0000-0001-7214-2786 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Parthenolide (PTN), a sesquiterpene lactone derived from the medicinal plant feverfew (
Indexed as
Anti-Inflammatory Agents, Non-SteroidalRespiratory Tract DiseasesSesquiterpenesAnimalsAntioxidantsHumansLactonesTanacetum partheniumAnti-Inflammatory Agents, Non-SteroidalAntioxidantsLactonesparthenolideSesquiterpenesACT001anti-inflammatory agentsDMAPTparthenoliderespiratory tract diseases
Identifiers
PMID41982760
PMCPMC13071162
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390